Fasken Martineau provides strategic counsel in all aspects of local and cross-border public M&A, including negotiated acquisitions and divestitures, joint ventures, strategic alliances and contested corporate transactions such as proxy battles and hostile take-overs.
We can respond quickly and effectively to any M&A transaction, regardless of timing, size, scope or complexity. Our experience with market leaders has established our reputation as a manager of large and complex M&A transactions and we frequently advise on complex cross-border transactions.
Members of our Public M&A group are recognized internationally in leading legal industry guides publications, including in:
- The Best Lawyers in Canada (2014) (for Corporate Governance, Corporate Law, Mergers & Acquisitions Law and Securities Law)
- The Canadian Legal Lexpert Directory (2014) (for Mergers & Acquisitions, Corporate Finance & Securities, Corporate Mid-Market, Private Equity and multiple other related practice areas)
- Chambers Global (2014) (for Corporate/M&A in Canada, the UK and India and Corporate/Commercial in Nigeria)
- Chambers UK (2015) (for Corporate/M&A Mid-Market and Capital Markets: AIM)
- The Legal 500 UK (2014) (for Corporate & Commercial - Flotations: Small and Mid-Cap and M&A: Smaller Deals up to £50m)
- Lexpert Guide to the Leading US/Canada Cross-border Corporate Lawyers (2013) and Lexpert (2013) (Fasken Martineau acted on 3 of the Top 10 Deals of 2013, including the Deal of the Year)
- Who's Who Legal (2014) (for Capital Markets and Corporate Governance)
We represent both domestic and foreign capital market participants in all aspects of a public M&A transaction. Our clients range from start-up enterprises to some of the world's leading public companies, financial institutions, private equity firms, asset managers, investment banks, investors and concerned shareholder groups, all of whom rely on us to provide focused, strategic advice specifically tailored to meet their business objectives.
- Negotiated acquisitions and divestitures
- Contested corporate transactions, including hostile take-over bids and proxy contests
- Leveraged buy outs
- Board and Special Committee representation
- Joint ventures and strategic alliances
- Shareholder advisory and rights planning
- Take-over defence mechanisms, including poison pills